<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>163(5)</volume><submitter>Olliges A</submitter><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>Deletion of the cyclooxygenase-2 (COX-2) gene causes impairment of kidney development, but the effect of selective inhibitors of COX-2 (coxibs) or the non-selective inhibitors of COX (the classical non-steroidal anti-inflammatory drugs; NSAIDs) on kidney development was less well described.&lt;h4>Experimental approach&lt;/h4>We assessed the effects of equipotent analgesic doses of celecoxib, rofecoxib, valdecoxib, etoricoxib and lumiracoxib and of the NSAIDs, diclofenac and naproxen, on postpartum kidney development in mice, from postnatal day 1 (P1) to P21.&lt;h4>Key results&lt;/h4>All the COX inhibitors, at the doses used, blocked COX-2 activity by more than 80% as assayed by PGE(2) synthesis in lipopolysaccharide-stimulated mouse blood samples. Rofecoxib, etoricoxib a</pubmed_abstract><journal>British journal of pharmacology</journal><pagination>927-36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3130940</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors.</pubmed_title><pmcid>PMC3130940</pmcid><pubmed_authors>Wimmer S</pubmed_authors><pubmed_authors>Olliges A</pubmed_authors><pubmed_authors>Nusing RM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors.</name><description>&lt;h4>Background and purpose&lt;/h4>Deletion of the cyclooxygenase-2 (COX-2) gene causes impairment of kidney development, but the effect of selective inhibitors of COX-2 (coxibs) or the non-selective inhibitors of COX (the classical non-steroidal anti-inflammatory drugs; NSAIDs) on kidney development was less well described.&lt;h4>Experimental approach&lt;/h4>We assessed the effects of equipotent analgesic doses of celecoxib, rofecoxib, valdecoxib, etoricoxib and lumiracoxib and of the NSAIDs, diclofenac and naproxen, on postpartum kidney development in mice, from postnatal day 1 (P1) to P21.&lt;h4>Key results&lt;/h4>All the COX inhibitors, at the doses used, blocked COX-2 activity by more than 80% as assayed by PGE(2) synthesis in lipopolysaccharide-stimulated mouse blood samples. Rofecoxib, etoricoxib a</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Jul</publication><modification>2025-05-29T21:53:11.814Z</modification><creation>2019-03-27T03:06:45Z</creation></dates><accession>S-EPMC3130940</accession><cross_references><pubmed>21391980</pubmed><doi>10.1111/j.1476-5381.2011.01313.x</doi></cross_references></HashMap>